HPV Vaccine Researcher Drops A Bombshell

Dr. Diane Harper, lead researcher in the development of two human papilloma virus vaccines, Gardasil and Cervarix, said the controversial drugs will do little to reduce cervical cancer rates and, even though they’re being recommended for girls as young as nine, there have been no efficacy trials in children under the age of 15. Dr. Harper, director of the Gynecologic Cancer Prevention Research Group at the University of Missouri, made these remarks during an address at the 4th International Public Conference on Vaccination which took place in Reston, Virginia on Oct. 2-4. Although her talk was intended to promote the vaccine, participants said they came away convinced the vaccine should not be received.
Read article in Alliance for Human Research Protection

Schools Secretary Ed Balls is at the centre of a controversy over the appointment of a top executive with the drugs company GSK to the board of Ofsted

The following paragraph is copied from http://www4.dr-rath-foundation.org/Newsletter/archive/newsletter_2008_07_jul_09.html

A scandal is mushrooming because the Schools Secretary has appointed a Glaxo exec to the board of the government's official education watchdog agency, known as Ofsted. And the move occurred less than a month before the government awarded a reported $200 million contract to Glaxo for its HPV vaccine for school-age girls 12 years and older, which some parents fear will give a green light to teenage sex, The Daily Mail reports. The appointment also comes at a time when a growing number of families are filing lawsuits against Glaxo over its Paxil antidepressent, claiming the drug caused suicide or attempted suicides.
Read article at pharmalot.com

Smells fishy to me...